| Literature DB >> 15196940 |
Lara S Shamieh1, Adam J Evans, Michael C Denton, Gail M Clinton.
Abstract
Retention of intron 8 in alternative HER-2 mRNA generates an inhibitory secreted ligand, Herstatin, with a novel receptor-binding domain (RBD) encoded by the intron. This study examines binding interactions with several receptors and investigates sequence variations in intron 8. The RBD, expressed as a peptide, binds at nM concentrations to HER-2, the EGFR, DeltaEGFR, HER-4 and to the IGF-1 receptor, but not to HER-3 nor to the FGF-3 receptor, whereas a rare mutation in the RBD (Arg to Ile) eliminates receptor binding. The full-length Herstatin binds with 3-4-fold higher affinity than its RBD, but with approximately 10-fold lower affinity to the IGF-IR. Sequence conservation in rhesus monkey but not in rat suggests that intron 8 recently diverged as a receptor-binding module critical for the function of Herstatin.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15196940 DOI: 10.1016/j.febslet.2004.05.027
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124